NBP607

BIOLOGICAL3 trials

Sponsors

SK Chemicals Co., Ltd.

Conditions

Influenza, HumanPrevention of Influenza

Phase 1

Safety, Tolerability and Immunogenicity of an Trivalent Inactivated Cell-Culture Influenza Vaccine in Healthy Adults

CompletedNCT03893669

SK Chemicals Co., Ltd.Prevention of Influenza

Start: 2012-09-30End: 2012-11-30Updated: 2019-03-28

Phase 3

Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Adult and Elderly Subjects

CompletedNCT02344134

SK Chemicals Co., Ltd.Influenza, Human

Start: 2013-09-30End: 2014-05-31Updated: 2015-01-22

Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Healthy Children and Adolescents

CompletedNCT02621177

SK Chemicals Co., Ltd.Influenza, Human

Start: 2013-11-30End: 2014-07-31Updated: 2015-12-03

Related Papers

Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trial.

2015-08-247 citations